Search results for: 'therapies'

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

This study explores the global immuno-oncology (I-O) markets evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune syst...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides strategic insights into frontier innovations redefining therapeutic development, precision diagnostics, and immune modulating interventions. It showcases breakthroughs across engineered phage therapeutics, intracellular peptide platforms, advanced gene ...

The global CGT therapeutics market is transitioning from a niche, high-complexity segment into a mainstream, high-growth therapeutic class. Driven by scientific breakthroughs, accelerated regulatory pathways, and the entry of next-generation platforms—including in vivo CRISPR gene editing, allogeneic “off-the-shelf” cell therapies, and automated sm...

This research service covers the U.S. compression therapy market in the United States. Further, market dynamics and revenue forecasts and analysis, and competitive landscape have been discussed for each of the segments static and dynamic compression therapy.

The U.S. Gene Therapy Market report provides timely information on the emerging gene therapy market. The report examines the overall market in terms of the primary factors driving growth and addresses the key challenges facing the market.

The objective of this research service is to evaluate the present state of the U.S. oxygen therapy devices markets, presenting a forecast and analysis of the revenues. The forecast period is from 2006 to 2012, with a base year of 2005. The research service also identifies the key challenges, major market and technology trends, the competitive stru...

This research service provides an understanding of the significance and impact of digital therapeutics on the emerging applications. Digital therapeutics is evidence-based therapeutic intervention for prevention, management, and treatment of a specific disease condition; it has the potential to address needs that traditional treatments and therapie...

This study analyses the compression therapy devices market trends, drivers and restraints in western Europe. Compression therapy is a type of treatment method used for patients with venous and lymphatic conditions. The market segments include static compression therapy devices, which can be further segmented as compression bandages and therapeutic ...